Abstract

Augmented renal clearance (ARC) is a manifestation of enhanced renal function seen in critically ill patients. The use of regular unadjusted doses of renally eliminated drugs in patients with ARC might lead to therapy failure. The purpose of this scoping review was to provide and up-to-date summary of the available evidence pertaining to the phenomenon of ARC. A literature search of databases of available evidence in humans, with no language restriction, was conducted. Databases searched were MEDLINE (1946 to April 2017), EMBASE (1974 to April 2017) and the Cochrane Library (1999 to April 2017). A total of 57 records were included in the present review: 39 observational studies (25 prospective, 14 retrospective), 6 case reports/series and 12 conference abstracts. ARC has been reported to range from 14 to 80%. ARC is currently defined as an increased creatinine clearance of greater than 130 mL/min/1.73 m2 best measured by 8–24 h urine collection. Patients exhibiting ARC tend to be younger (<50 years old), of male gender, had a recent history of trauma, and had lower critical illness severity scores. Numerous studies have reported antimicrobials treatment failures when using standard dosing regimens in patients with ARC. In conclusion, ARC is an important phenomenon that might have significant impact on outcome in critically ill patients. Identifying patients at risk, using higher doses of renally eliminated drugs or use of non-renally eliminated alternatives might need to be considered in ICU patients with ARC. More research is needed to solidify dosing recommendations of various drugs in patients with ARC.

Highlights

  • Studying the influence of renal dysfunction on the pharmacokinetics of drugs is an important consideration in drug development

  • Augmented renal clearance (ARC) is a manifestation of enhanced renal function seen in critically ill patients [1,2]

  • The current evidence presented in this review identified the significance of this phenomenon and the need for higher doses of renally eliminated drugs in patients with ARC

Read more

Summary

Introduction

Studying the influence of renal dysfunction on the pharmacokinetics of drugs is an important consideration in drug development. Little attention is given if patients exhibit an augmented renal clearance (ARC). Augmented renal clearance (ARC) is a manifestation of enhanced renal function seen in critically ill patients [1,2]. It is currently defined as an increased creatinine clearance of greater than. ARC is a clinical phenomenon rapidly gaining recognition in the world of critical care. ARC may have existed long before our current recognition, it wasn’t until the early

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call